This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
💨 Why Chest Infections Keep Coming Back — and What Can Help
October 21, 2025
🧬 The Story of Brensocatib: A New Way to Calm Lung Inflammation
October 21, 2025
🌟 Vitamin B12 (Cobalamin) and Iron – What Patients Should Know
October 17, 2025
💬 Healthwatch: Your Local Voice in the NHS
October 16, 2025
🎢 Life as a Patient
October 14, 2025
Living Between What My Body Needs and What the World Expects
October 14, 2025
News archive
- Air pollution
- Allergy or Intolerance
- Antifungals in development
- Antimicrobial resistance
- COVID-19
- Carers
- Climate change
- Damp
- Diagnostics
- Events
- Fundraising
- GP Guidance
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle
- Lifestyle and Coping Skills
- Living with Aspergillosis
- Mental Health
- Mycotoxins
- NAC announcements
- NHS
- News archive
- Palliative care
- Patient and Carer Blog
- Patient stories
- Professional Guidance
- Questions
- Recordings
- Research
- Research Summaries
- Side Effects
- Supplements and complementary therapies
- Travel
- Treatment
- Types of aspergillosis
- Video
- Weekly Updates
